|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,983 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,070,832 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 33 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-11-02 |
4 |
AS |
$97.88 |
$146,820 |
D/D |
(1,500) |
288,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-09-04 |
4 |
AS |
$98.16 |
$147,240 |
D/D |
(1,500) |
285,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-01-09 |
4 |
AS |
$98.19 |
$981,900 |
D/D |
(10,000) |
425,162 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-02-05 |
4 |
AS |
$98.63 |
$394,520 |
D/D |
(4,000) |
288,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-05 |
4 |
AS |
$99.00 |
$495,000 |
D/D |
(5,000) |
238,496 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-01-08 |
4 |
A |
$99.05 |
$4,953 |
D/D |
50 |
425,162 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-10-03 |
4 |
AS |
$99.36 |
$149,040 |
D/D |
(1,500) |
286,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-04-10 |
4 |
AS |
$99.56 |
$995,600 |
D/D |
(10,000) |
425,896 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2016-12-30 |
4 |
A |
$100.27 |
$14,439 |
D/D |
144 |
1,069 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-07-23 |
4 |
AS |
$101.69 |
$152,535 |
D/D |
(1,500) |
285,290 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-06-30 |
4 |
A |
$103.97 |
$21,626 |
D/D |
208 |
9,190 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-12-02 |
4 |
S |
$103.97 |
$155,967 |
D/D |
(1,500) |
321,424 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2015-07-01 |
4 |
A |
$104.21 |
$13,235 |
D/D |
127 |
127 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-12-13 |
4 |
S |
$106.89 |
$106,890 |
D/D |
(1,000) |
320,424 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-03 |
4 |
AS |
$107.42 |
$537,097 |
D/D |
(5,000) |
215,157 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-04 |
4 |
AS |
$107.71 |
$98,660 |
I/I |
(916) |
42,279 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-02 |
4 |
AS |
$107.96 |
$323,893 |
I/I |
(3,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-10-15 |
4 |
AS |
$108.24 |
$108,241 |
I/I |
(1,000) |
26,758 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-02 |
4 |
AS |
$108.44 |
$542,195 |
D/D |
(5,000) |
220,157 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2015-12-31 |
4 |
A |
$108.45 |
$14,424 |
D/D |
133 |
391 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-02-13 |
4 |
AS |
$109.15 |
$654,900 |
D/D |
(6,000) |
320,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-02-10 |
4 |
AS |
$110.11 |
$1,651,650 |
D/D |
(15,000) |
320,324 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2015-10-01 |
4 |
A |
$110.33 |
$14,453 |
D/D |
131 |
258 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-01-17 |
4 |
AS |
$111.55 |
$1,115,500 |
D/D |
(10,000) |
320,424 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-09 |
4 |
S |
$112.12 |
$2,130,383 |
I/I |
(19,000) |
38,279 |
0 |
- |
|
850 Records found
|
|
Page 33 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|